Sino Biopharmaceutical Limited
Save
–
Market cap
35.61x
Current P/E
18.98x
Forward P/E
About
Health care
Sector
Biotechnology
Industry
Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company offers oncology medicines comprising Qingkeshu tablets, Focus V capsules, Annike injection, and Anyue capsules; liver disease medicines, including Tianqing ganmei injection and Runzhong dispersible tablets; and respiratory system medicines, such as Tianqing suchang suspension for inhalation and Tianyun for injection.
Similar securities
Based on sector and market capitalization
Report issue